Cellular distribution, metabolism and regulation of the xanthine oxidoreductase enzyme system

Chemico-Biological Interactions

Volumn 129, Issue 1-2, 2000, Pages 195-208

  Pritsos, Chris A ^a  

^a UNIVERSITY OF NEVADA   (United States)

Author keywords

Metabolism; Regulation; Xanthine dehydrogenase; Xanthine oxidase

Indexed keywords

ANTINEOPLASTIC AGENT; FLAVOPROTEIN; GENE PRODUCT; MOLYBDENUM; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE; XENOBIOTIC AGENT;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CATABOLISM; CELLULAR DISTRIBUTION; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME METABOLISM; ENZYME REGULATION; GENE STRUCTURE; HUMAN; INFLAMMATORY DISEASE; NONHUMAN; PROTEIN FAMILY; XENOBIOTIC METABOLISM;

ANIMALS; ARTERIOSCLEROSIS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INFLAMMATION; PURINES; SUBSTRATE SPECIFICITY; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE; XENOBIOTICS;

EID: 0034534036     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(00)00203-9     Document Type: Article

References (67)

1. Xanthine oxidase: Biochemistry, distribution and physiology
2. Organ distribution and molecular forms of human xanthine dehydrogenase/xanthine oxidase protein
3. cDNA cloning, characterization, and tissue-specific expression of human xanthine dehydrogenase/xanthine oxidase
4. Identification of the candidate ALS2 gene at chromosome 2q33 as a human aldehyde oxidase gene
5. Molecular cloning, tissue expression of human xanthine dehydrogenase
6. Molecular cloning, tissue expression of human xanthine dehydrogenase
7. Xanthine oxidoreductase gene expression and enzyme activity in developing human tissues
8. Distribution of xanthine dehydrogenase and oxidase activities in human and rabbit tissues
9. Xanthine oxidase as a source of free radical damage in myocardiol ischemia
10. Oxygen-derived free radicals in postischemic tissue injury
11. Role of xanthine oxidase is ischemia/reperfusion
12. Role of xanthine oxidase and neutriphils in ischemia-reperfusion injury in rabbit lung
13. Generation of superoxide anion by brain endothelial cell xanthine oxidase
14. Significance of xanthine oxidase in capillary endothelial cells
15. Purification and immunohistochemical tissue localization of human xanthine oxidase
16. Immunoaffinity localization of the enzyme xanthine oxidase on the outside surface of the endothelial cell plasma membrane
17. Circulating xanthine oxidase: Potential mediator of ischemic injury
18. Circulating xanthine oxidase in human ischemia reperfusion
19. Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface
20. Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of xanthine oxidase (EC 1.2.3.2)
21. Decreased concentration of xanthine dehydrogenase (EC 1.1.1.204) in rat hepatomas
22. Colon tumor: Enzymology of the neoplastic program
23. Increased amidophosphoribosyltransferase and decreased xanthine oxidase activity in human and rat renal cell carcinoma
24. Activities of the enzymes participating in purine and free-radical metabolism in cancerous human colorectal tissues
25. Activities of DNA turnover and free radical metolizing enzymes in cancerous human prostate tissue
26. Induction of DT-diaphorase by 1,2-dithiole-3-thiones in human tumour and normal cells and effect on anti-tumor activity of bioreductive agents
27. Inhibition of DT-diaphorase (NAD(P)H: Quinone oxidoreuctase, EC 1.6.99.2) by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and flavone-8-acetic acid (FAA): Implications for bioreductive drug development
28. Regulation of xanthine dehydrogenase and xanthine oxidase activity by hypoxia
29. Hypoxia regulates xanthine dehydrogenase activity at pre and posttranslational levels
30. Studies of the reductive half-reaction of milk xanthine dehydrogenase
31. 2-dependent types of rat liver xanthine dehydrogenase
32. The reaction of reduced xanthine dehydrogenase with molecular oxygen
33. Recent mechanistic studies of xanthine oxidase
34. Role of the flavin midpoint potential and NAD binding in determining NAD versus oxygen reactivity of xanthine oxidoreductase
35. A comparison of the specificities of xanthine oxidase and aldehyde oxidase
36. A comparison of the distribution and electron acceptor specificities of xanthine oxidase and aldehyde oxidase
37. Studies on the specificity toward aldehyde substrates and steady-state kinetics of xanthine oxidase
38. Xanthine oxidase-mediated decomposition of S-nitrosothiols
39. Generation of nitric oxide by a nitrite reductase activity of xanthine oxidase: A potential pathway for nitric oxide formation in the absence of nitric oxide synthase activity
40. Valaciclovir: An improvement over acyclovir for the treatment of zoster
41. 6-deoxyacyclovir: A xanthine oxidase-activated prodrug of acyclovir
42. Xanthine oxidase catalyzed reductive cleavage of anthracycline antibiotics and free radical formation
43. Loss of fluorescence by anthracycline antibiotics: Effects of xanthine oxidase and identification of the nonfluorescent metabolites
44. Comparative flavoprotein catalysis of anthracycline antibiotic
45. Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH cytochrome P-450 reductase and xanthine oxidase
46. Bioactivation of mitomycin C by xanthine dehydrogenase from EMT6 mouse mammary carcinoma tumors
47. Kinetics and mechanism of mitomycin C bioactivation by xanthine dehydrogenase under aerobic and hypoxic condition
48. Comparison of oxygen radical generation from the reductive activation of doxorubicin, streptonigrin and menadione by xanthine oxidase and xanthine dehydrogenase
49. Reductive activation of doxorubicin by xanthine dehydrogenase from EMT6 mouse mammary carcinoma tumors
50. The xanthine dehydrogenase gene: Structure and regulation
51. Flavoprotein structure and mechanism 4. Xanthine oxidase and xanthine dehydrogenase
52. 2-dependent type
53. Cloning of the cDNA encoding human xanthine dehydrogenase (oxidase): Structural analysis of the protein and chromosomal location of the gene
54. Cloning and expression in vitro of human xanthine dehydrogenase/oxidase
55. Molecular cloning of a cDNA coding for mouse liver xanthine dehydrogenase
56. Analysis of aldehyde oxidase and xanthine dehydrogenase/oxidase as possible candidate genes for autosomal recessive familial amyotrophic lateral sclerosis
57. Assignment of human xanthine dehydrogenase gene to chromosome 2p22
58. The human gene for xanthine dehydrogenase (XDH) is localized on chromosome band 2p22
59. Molecular cloning and characterization of the human xanthine dehydrogenase
60. Regulation of xanthine dehydrogenase and xanthine oxidase activity and gene expression in cultured rat pulmonary endothelial cells
61. Interferons induce xanthine dehydrogenase gene expression in L929 cells
62. Xanthine dehydrogenase and xanthine oxidase activity and gene expression in renal epithelial cells
63. Regulation of xanthine dehydrogenase in rat liver in response to peroxisome proliferators
64. Regulation of hepatic xanthine oxidoreductase expression by treatment of rats with xenobiotic agents
65. 2 metabolites inactivate xanthine oxidase
66. The contribution of vascular endothelial xanthine dehydrogenase/oxidase to oxygen-mediated cell injury
67. Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity